Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Food and drink companies are innovating around GLP-1 users
Ultimately, Pfizer discontinued the entire program in April 2025, citing that the risk-benefit profile, including a potential case of drug-induced liver injury (DILI) in a recent study, did not support further development
They will evaluate your current dose, health goals, and how well your body responds to the medication, among other factors, before offering their recommendation
Remember, small changes add up over time
US$ 26.74
US$ 23.86
US$ 27.57
US$ 25.26
US$ 29.77
US$ 29.32
US$ 22.79
